Key Points
- Doximity director Kira Scherer Wampler sold 2,000 shares at an average price of $24.95, totaling $49,900. The Rule 10b5-1 transaction reduced her position by 9.16%, leaving her with 19,839 shares.
- Doximity recently reported quarterly EPS of $0.29, beating the $0.16 consensus estimate, while revenue rose 7.3% year over year to $156.62 million.
- Analysts have a consensus “Hold” rating on DOCS, with an average price target of $32.43 versus the stock’s reported price of $25.60; institutional investors own 87.19% of the shares.
Doximity, Inc. (NYSE:DOCS - Get Free Report) Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $24.95, for a total value of $49,900.00. Following the completion of the sale, the director owned 19,839 shares of the company's stock, valued at $494,983.05. The trade was a 9.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Doximity Stock Up 3.5%
Shares of NYSE DOCS opened at $25.60 on Friday. The firm's fifty day moving average is $22.58 and its 200 day moving average is $23.05. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $76.51. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 30.12, a PEG ratio of 19.35 and a beta of 1.29.
Doximity (NYSE:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.13. The firm had revenue of $156.62 million for the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. Doximity's revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.36 EPS. Equities research analysts anticipate that Doximity, Inc. will post 0.74 earnings per share for the current year.
Wall Street Analyst Weigh In
Several research analysts have commented on DOCS shares. Truist Financial upped their price objective on shares of Doximity from $19.00 to $24.00 and gave the stock a "hold" rating in a report on Thursday, August 13th. Bank of America reissued an "underperform" rating and issued a $20.00 price target (down from $38.00) on shares of Doximity in a research note on Monday, June 29th. Canaccord Genuity Group set a $36.00 price objective on Doximity in a research report on Friday, August 7th. Piper Sandler reiterated an "overweight" rating and set a $47.00 target price (up from $42.00) on shares of Doximity in a report on Friday, August 7th. Finally, Leerink Partners lowered their target price on Doximity from $31.00 to $25.00 and set an "outperform" rating for the company in a research note on Thursday, May 14th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $32.43.
Check Out Our Latest Report on DOCS
Hedge Funds Weigh In On Doximity
Several large investors have recently made changes to their positions in DOCS. Vanguard Group Inc. raised its stake in Doximity by 4.1% during the fourth quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company's stock valued at $588,281,000 after buying an additional 518,916 shares during the last quarter. Carmignac Gestion lifted its holdings in shares of Doximity by 127.8% during the first quarter. Carmignac Gestion now owns 4,311,997 shares of the company's stock valued at $100,480,000 after purchasing an additional 2,418,971 shares in the last quarter. UBS Group AG boosted its holdings in shares of Doximity by 26.5% during the 4th quarter. UBS Group AG now owns 680,260 shares of the company's stock valued at $30,122,000 after acquiring an additional 142,408 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in Doximity by 325,436.6% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company's stock worth $57,515,000 after purchasing an additional 1,298,492 shares during the period. Finally, Royal Bank of Canada increased its position in Doximity by 28.4% during the first quarter. Royal Bank of Canada now owns 206,282 shares of the company's stock valued at $4,806,000 after acquiring an additional 45,618 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.
Doximity Company Profile
(
Get Free Report)
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
